Folke Sjöqvist

14.9k total citations · 1 hit paper
208 papers, 11.6k citations indexed

About

Folke Sjöqvist is a scholar working on Pharmacology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Folke Sjöqvist has authored 208 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Pharmacology, 49 papers in Pharmacology and 47 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Folke Sjöqvist's work include Pharmacogenetics and Drug Metabolism (57 papers), Pharmaceutical studies and practices (30 papers) and Pharmacological Effects and Toxicity Studies (24 papers). Folke Sjöqvist is often cited by papers focused on Pharmacogenetics and Drug Metabolism (57 papers), Pharmaceutical studies and practices (30 papers) and Pharmacological Effects and Toxicity Studies (24 papers). Folke Sjöqvist collaborates with scholars based in Sweden, United States and United Kingdom. Folke Sjöqvist's co-authors include Leif Bertilsson, Marja‐Liisa Dahl, Anders Rane, Magnus Ingelman‐Sundberg, Juliette Säwe, Magnus Borga, Marie Åsberg, Inger Johansson, Börje Cronholm and D. Tuck and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Folke Sjöqvist

204 papers receiving 10.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.

1993 504 citations Leif Bertilsson, Marja‐Liisa Dahl et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Folke Sjöqvist Sweden	57	4.6k	2.7k	2.2k	2.1k	2.1k	208	11.6k
Jerold S. Harmatz United States	65	4.0k 0.9×	2.4k 0.9×	1.7k 0.8×	1.7k 0.8×	2.7k 1.3×	236	11.8k
W. Kalow Canada	57	4.0k 0.9×	2.9k 1.1×	1.2k 0.6×	1.6k 0.7×	863 0.4×	237	11.1k
Richard I. Shader United States	81	5.2k 1.1×	4.0k 1.5×	2.9k 1.3×	2.3k 1.1×	5.5k 2.6×	549	21.5k
Leif Bertilsson Sweden	71	8.7k 1.9×	3.5k 1.3×	3.1k 1.4×	3.8k 1.8×	3.8k 1.8×	292	17.5k
Kim Brøsen Denmark	62	4.8k 1.0×	2.4k 0.9×	1.8k 0.8×	2.2k 1.0×	1.4k 0.7×	233	11.0k
Meindert Danhof Netherlands	61	2.4k 0.5×	2.7k 1.0×	3.3k 1.5×	2.0k 0.9×	1.7k 0.8×	496	15.3k
Gerhard Levy United States	59	3.3k 0.7×	2.5k 0.9×	2.4k 1.1×	1.4k 0.6×	466 0.2×	427	13.5k
Marja‐Liisa Dahl Sweden	53	4.5k 1.0×	1.6k 0.6×	1.2k 0.5×	1.7k 0.8×	2.2k 1.0×	149	8.6k
Anders Rane Sweden	56	4.4k 0.9×	1.4k 0.5×	3.4k 1.5×	1.8k 0.9×	990 0.5×	361	12.7k
Geoffrey T. Tucker United Kingdom	58	4.9k 1.1×	1.8k 0.7×	2.0k 0.9×	2.8k 1.3×	546 0.3×	190	12.0k

Countries citing papers authored by Folke Sjöqvist

Since Specialization

Citations

This map shows the geographic impact of Folke Sjöqvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Folke Sjöqvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Folke Sjöqvist more than expected).

Fields of papers citing papers by Folke Sjöqvist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Folke Sjöqvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Folke Sjöqvist. The network helps show where Folke Sjöqvist may publish in the future.

Co-authorship network of co-authors of Folke Sjöqvist

This figure shows the co-authorship network connecting the top 25 collaborators of Folke Sjöqvist. A scholar is included among the top collaborators of Folke Sjöqvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Folke Sjöqvist. Folke Sjöqvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Orme, Michael & Folke Sjöqvist. (2013). Clinical Pharmacology in European health care—outcome of a questionnaire study in 31 countries. European Journal of Clinical Pharmacology. 69(9). 1635–1639. 6 indexed citations

Gustafsson, Lars L., Björn Wettermark, Brian Godman, et al.. (2011). The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm. Basic & Clinical Pharmacology & Toxicology. 108(4). 224–233. 184 indexed citations

Sjöqvist, Folke. (2009). Clinical Pharmacology - current importance and future perspectives. 23(1). 5. 1 indexed citations

Sjöqvist, Folke, et al.. (2006). The Use of TDM Data to Assess the Validity of Defined Daily Doses of Antiepileptics: A Comparison Between a Czech and Swedish University Hospital. Therapeutic Drug Monitoring. 28(5). 589–593. 7 indexed citations

Taipalensuu, Jan, Hans Törnblom, Greger Lindberg, et al.. (2001). Correlation of Gene Expression of Ten Drug Efflux Proteins of the ATP-Binding Cassette Transporter Family in Normal Human Jejunum and in Human Intestinal Epithelial Caco-2 Cell Monolayers. Journal of Pharmacology and Experimental Therapeutics. 299(1). 164–170. 351 indexed citations

Sjöqvist, Folke. (2000). Drug Safety in Relation to Efficacy: The View of a Clinical Pharmacologist. Pharmacology & Toxicology. 86(s1). 30–32. 13 indexed citations

Sjöqvist, Folke. (1999). The past, present and future of clinical pharmacology. European Journal of Clinical Pharmacology. 55(8). 553–557. 19 indexed citations

Yamada, Hiroshi, Marja‐Liisa Dahl, L. Lannfelt, et al.. (1998). CYP2D6 and CYP2C19 genotypes in an elderly Swedish population. European Journal of Clinical Pharmacology. 54(6). 479–481. 45 indexed citations

Isacsson, Göran, et al.. (1996). The Use of Antidepressants and Therapeutic Drug Monitoring by General Practitioners and Psychiatrists: Findings from a Questionnaire Survey in Two Swedish Areas. Annals of Clinical Psychiatry. 8(3). 153–160. 18 indexed citations

10.

Johansson, Inger, Qun‐Ying Yue, Juliette Säwe, et al.. (1992). INTERETHNIC DIFFERENCES IN DRUG OXIDATION. IMPLICATIONS FOR THE UTILIZATION OF ANTIDEPRESSANTS AND NEUROLEPTICS. Clinical Neuropharmacology. 15. 88A–89A. 2 indexed citations

11.

Dahl, Marja‐Liisa, et al.. (1992). Analysis of the CYP2D6 gene in relation to debrisoquin and desipramine hydroxylation in a Swedish population. Clinical Pharmacology & Therapeutics. 51(1). 12–17. 163 indexed citations

12.

Dahlqvist, R., et al.. (1990). A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.. British Journal of Clinical Pharmacology. 30(3). 443–452. 40 indexed citations

13.

Villén, Tomás, Leif Bertilsson, & Folke Sjöqvist. (1990). Nonstereoselective Disposition of Ethosuximide in Humans. Therapeutic Drug Monitoring. 12(5). 514–514. 17 indexed citations

14.

Alván, Gunnar, Margaretha Grind, Christina Graffner, & Folke Sjöqvist. (1984). Relationship of N-demethylation of amiflamine and its metabolite to debrisoquine hydroxylation polymorphism. Clinical Pharmacology & Therapeutics. 36(4). 515–519. 25 indexed citations

15.

Bertilsson, Leif, Michel Eichelbaum, Britt Mellström, Juliette Säwe, & Folke Sjöqvist. (1982). Metabolism of various drugs in subjects with different debrisoquine and sparteine oxidation phenotypes. British Journal of Clinical Pharmacology. 14(4). 602. 1 indexed citations

16.

Sjöqvist, Folke. (1979). Monitoring of antidepressant drug plasma levels: The next ten years. Progress in Neuro-Psychopharmacology. 3(1-3). 201–210. 1 indexed citations

17.

Boman, G, et al.. (1976). Acetylator Phenotype in Patients with Hydralazine‐induced Lupoid Syndrome. Acta Medica Scandinavica. 200(1-6). 367–371. 73 indexed citations

18.

Åsberg, Marie, Börje Cronholm, Folke Sjöqvist, & D. Tuck. (1971). Relationship between Plasma Level and Therapeutic Effect of Nortriptyline. BMJ. 3(5770). 331–334. 341 indexed citations

19.

Alexanderson, B., David A. Evans, & Folke Sjöqvist. (1969). Steady-state plasma levels of nortriptyline in twins: Influence of genetic factors and drug therapy. BMJ. 4(5686). 764–768. 270 indexed citations

20.

Sjöqvist, Folke & Louis Lasagna. (1967). The hypnotic efficacy of doxylamine. Clinical Pharmacology & Therapeutics. 8(1part1). 48–54. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact